Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies

ConclusionOur results offer a promising role of combination therapies in cancer therapy as well as angiogenesis.

Source: Cancer Chemotherapy and Pharmacology - January 6, 2022 Category: Cancer & Oncology Source Type: research